ArticleJournal of cancer research and clinical oncology2009

Loss of PTEN function may account for reduced proliferation pathway sensitivity to LY294002 in human prostate and bladder cancer cells.

Shigeru Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.